(19)
(11)EP 3 211 094 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
01.11.2017 Bulletin 2017/44

(43)Date of publication A2:
30.08.2017 Bulletin 2017/35

(21)Application number: 16203656.0

(22)Date of filing:  02.09.2010
(27)Previously filed application:
 02.09.2010 PCT/US2010/047734
(51)International Patent Classification (IPC): 
C12Q 1/68(2006.01)
A61K 38/16(2006.01)
G01N 33/53(2006.01)
G01N 33/564(2006.01)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)Priority: 03.09.2009 US 275948 P
16.10.2009 US 252424 P

(62)Application number of the earlier application in accordance with Art. 76 EPC:
10814522.8 / 2473637

(71)Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72)Inventors:
  • DENNIS, Jr., Glynn
    South San Francisco, CA 94080 (US)
  • MARTIN, Flavius
    South San Francisco, CA 94080 (US)
  • TOWNSEND, Michael J.
    South San Francisco, CA 94080 (US)

(74)Representative: Winkler, Thomas 
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

  


(54)METHODS FOR TREATING, DIAGNOSING, AND MONITORING RHEUMATOID ARTHRITIS


(57) Methods of identifying, diagnosing, and prognosing rheumatoid arthritis are provided, as well as methods of treating rheumatoid arthritis. Also provided are methods for identifying effective rheumatoid arthritis therapeutic agents and predicting responsiveness to rheumatoid arthritis therapeutic agents.





Search report



























Search report